Results 91 to 100 of about 2,859 (123)

Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial. [PDF]

Eur Heart J, 2023
Schwartz GG, Szarek M, Bhatt DL, Bittner VA, Bujas-Bobanovic M, Diaz R, Fazio S, Fras Z, Goodman SG, Harrington RA, Jukema JW, Manvelian G, Pordy R, Ray KK, Scemama M, White HD, Steg PG, ODYSSEY OUTCOMES Investigators.   +17 more
europepmc   +1 more source

1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry. [PDF]

Int J Cardiol Heart Vasc, 2020
Chandrasekhar J, Baber U, Sartori S, Aquino MB, Hájek P, Atzev B, Hudec M, Kiam Ong T, Mates M, Borisov B, Warda HM, den Heijer P, Wojcik J, Iniguez A, Coufal Z, Khashaba A, Munawar M, Gerber RT, Yan BP, Tejedor P, Kala P, Bang Liew H, Lee M, Kalkman DN, Dangas GD, de Winter RJ, Colombo A, Mehran R, MASCOT investigators.   +28 more
europepmc   +1 more source

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. [PDF]

Circulation, 2022
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG, ODYSSEY OUTCOMES Investigators.   +19 more
europepmc   +1 more source

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment. [PDF]

Diabetes Care, 2021
Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG, ODYSSEY OUTCOMES Committees and Investigators.   +12 more
europepmc   +1 more source

Liquified Petroleum Gas (LPG) Supply and Demand for Cooking in Northern Ghana. [PDF]

Ecohealth, 2018
Dalaba M, Alirigia R, Mesenbring E, Coffey E, Brown Z, Hannigan M, Wiedinmyer C, Oduro A, Dickinson KL.   +8 more
europepmc   +1 more source

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol. [PDF]

J Am Coll Cardiol, 2021
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P, ODYSSEY Outcomes Committees and Investigators.   +14 more
europepmc   +1 more source

Why can't I see after my heart is fixed: a case series of ocular complications after cardiac intervention. [PDF]

BMC Ophthalmol, 2016
Hsien YM, Mustapha M, Hamzah JC, Maskon O, Ken CC, Hamdi CH.   +5 more
europepmc   +1 more source